← Back to Clinical Trials
Recruiting NCT06724744

NCT06724744 Manual Diaphragmatic Release on Ventilatory Functions in Elderly Diabetic Women

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06724744
Status Recruiting
Phase
Sponsor Cairo University
Condition Diabetes
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2024-09-15
Primary Completion 2025-02-01

Eligibility & Interventions

Sex Female only
Min Age 65 Years
Max Age 70 Years
Study Type INTERVENTIONAL
All Conditions
Interventions
Aerobic trainingManual Diaphragm Release

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2024-09-15 with a primary completion date of 2025-02-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Evaluate the effect of manual diaphragmatic release on ventilatory functions and functional capacity in elderly diabetic women.

Eligibility Criteria

Inclusion Criteria: * Type 2 diabetic for more than 5 years. * Well controlled diabetes with glycated hemoglobin≤7%. * Normal to mild ventilatory functions impairment. * Their ages ranges from 65 to 70 years old. * Their body mass index are less than 30 Kg/m2. Exclusion Criteria: * Other types of diabetes. * Patients with any other chronic chest diseases . * Cardiovascular disorders (coronary heart disease, heart failure, cardiac arrhythmia, peripheral arterial disease, uncontrolled hypertension). * Smokers. * Rheumatoid arthritis. * Musculoskeletal/ neurological limitations to exercise.

Contact & Investigator

Central Contact

Saad Mohamed Elgendy, Ph.D

✉ saherelgayar@yahoo.com

📞 +201020429911

Principal Investigator

Saher Lotfy Elgayar, Ph.D

STUDY DIRECTOR

Department of Physiotherapy Faculty of Allied Medical Sciences Middle East University Amman Jordan

Frequently Asked Questions

Who can join the NCT06724744 clinical trial?

This trial is open to female participants only, aged 65 Years or older, up to 70 Years, studying Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06724744 currently recruiting?

Yes, NCT06724744 is actively recruiting participants. Contact the research team at saherelgayar@yahoo.com for enrollment information.

Where is the NCT06724744 trial being conducted?

This trial is being conducted at Al Mansurah, Egypt.

Who is sponsoring the NCT06724744 clinical trial?

NCT06724744 is sponsored by Cairo University. The principal investigator is Saher Lotfy Elgayar, Ph.D at Department of Physiotherapy Faculty of Allied Medical Sciences Middle East University Amman Jordan. The trial plans to enroll 60 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology